Pharma stocks tumble after US imposes 100% tariff on branded pharmaceutical exports

26 Sep 2025 Evaluate

Indian pharmaceutical stocks declined after US President Donald Trump's move to impose 100% import tariffs on pharmaceutical drugs from October 1.

Sun Pharmaceutical Industries is currently trading at Rs. 1579.35, down by 48.65 points or 2.99% from its previous closing of Rs. 1628.00 on the BSE. The scrip opened at Rs. 1590.60 and has touched a high and low of Rs. 1602.90 and Rs. 1547.25 respectively. So far 246150 shares were traded on the counter. 

Lupin is currently trading at Rs. 1927.00, down by 34.45 points or 1.76% from its previous closing of Rs. 1961.45 on the BSE. The scrip opened at Rs. 1923.30 and has touched a high and low of Rs. 1950.65 and Rs. 1912.90 respectively. So far 20214 shares were traded on the counter.

Dr. Reddy's Laboratories is currently trading at Rs. 1255.25, down by 19.55 points or 1.53% from its previous closing of Rs. 1274.80 on the BSE. The scrip opened at Rs. 1248.10 and has touched a high and low of Rs. 1277.95 and Rs. 1245.30 respectively. So far 75324 shares were traded on the counter.

US President Donald Trump has imposed 100% tariffs on branded and patented pharmaceutical exports. The move has rattled Indian pharma stocks, even though most companies earn from US markets by selling generic drugs. On Indian pharmaceutical exports front, the US represents the primary market, comprising approximately 35% of total exports, with a value reaching about $10 billion in FY25.

Sun Pharma Inds. Share Price

1782.80 -14.45 (-0.80%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×